As of 2026-09-13, the EV/EBITDA ratio of OPKO Health Inc (OPK) is -2.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPK's latest enterprise value is 1,224.07 mil USD. OPK's TTM EBITDA according to its financial statements is -469.52 mil USD. Dividing these 2 quantities gives us the above OPK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 20.6x | 14.7x |
| Forward P/E multiples | 12.6x - 14.6x | 13.6x |
| Fair Price | (8.01) - (9.26) | (8.96) |
| Upside | -610.2% - -689.5% | -670.5% |
| Date | EV/EBITDA |
| 2026-09-09 | -2.56 |
| 2026-09-08 | -2.64 |
| 2026-09-04 | -2.72 |
| 2026-09-03 | -2.67 |
| 2026-09-02 | -2.80 |
| 2026-09-01 | -2.53 |
| 2026-08-31 | -2.45 |
| 2026-08-28 | -2.46 |
| 2026-08-27 | -2.50 |
| 2026-08-26 | -2.51 |
| 2026-08-25 | -2.48 |
| 2026-08-24 | -2.46 |
| 2026-08-21 | -2.46 |
| 2026-08-20 | -2.43 |
| 2026-08-19 | -2.43 |
| 2026-08-18 | -2.27 |
| 2026-08-17 | -2.27 |
| 2026-08-14 | -2.31 |
| 2026-08-13 | -2.34 |
| 2026-08-12 | -2.32 |
| 2026-08-11 | -2.32 |
| 2026-08-10 | -2.32 |
| 2026-08-07 | -2.29 |
| 2026-08-06 | -2.21 |
| 2026-08-05 | -2.26 |
| 2026-08-04 | -2.19 |
| 2026-08-03 | -2.19 |
| 2026-07-31 | -2.21 |
| 2026-07-30 | -2.23 |
| 2026-07-29 | -2.28 |
| 2026-07-28 | -2.73 |
| 2026-07-27 | -2.08 |
| 2026-07-24 | -2.05 |
| 2026-07-23 | -1.97 |
| 2026-07-22 | -1.99 |
| 2026-07-21 | -2.03 |
| 2026-07-20 | -2.02 |
| 2026-07-17 | -2.00 |
| 2026-07-16 | -2.00 |
| 2026-07-15 | -2.02 |
| 2026-07-14 | -2.05 |
| 2026-07-13 | -2.07 |
| 2026-07-10 | -2.26 |
| 2026-07-09 | -2.32 |
| 2026-07-08 | -2.35 |
| 2026-07-07 | -2.48 |
| 2026-07-06 | -2.50 |
| 2026-07-02 | -2.53 |
| 2026-07-01 | -2.54 |
| 2026-06-30 | -2.50 |